Comparing Between Mulligan Technique and Active Release Technique in Treatment of Chronic Mechanical Neck Pain
Not yet recruitingNot applicableNCT07679438
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
This study will be conducted to compare between Mulligan mobilization technique and Active release technique in management of non-specific chronic neck pain as regard to neck pain, cervical range of motion and neck function.
Study details
- Official title
- Effect of Mulligan Mobilization Technique Versus Active Release Technique on Chronic Non-specific Neck Pain
- Conditions
- Interventions
- Other: Conventional treatment
- Other: mulligan mobilization
- Other: active release technique
- Sponsor
- Cairo University
- Start date
- 2026-07
- Primary completion
- 2026-08
- Sex
- All
- Age range
- from 18 Years to 40 Years
- Results posted
- No results posted in this snapshot
- Total sites listed
- 0
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Inclusion Criteria The participants will be included in this study if they meet the following criteria: 1. Have referred from orthopedic surgeon diagnosed with NSCNP that has been localized to the cervical and periscapular areas for at least three months 2. Aged from 18-40 years 3. Having a score more than 10 on the Neck disability index (NDI) 4. BMI from 18.5 to 29.9 kg/m2. Exclusion Criteria: The Participants will be excluded from this study if they meet any of the following criteria 1. History of previous neck surgery. 2. Recent or old fractures. 3. Cognitive impairment and inability to understand the scale. 4. Systematic inflammatory disease e.g., rheumatoid arthritis and ankylosing spondylitis, neck pain with radiculopathy or neuropathy. 5. A score of below 10 or above 40 points out of 50 on the NDI.
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT07679438